DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Goto S. et al.
Double-blind, placebo-controlled phase II studies of the protease-activated receptor 1 antagonist E5555 (atopaxar) in japanese patients with acute coronary syndrome or high-risk coronary artery disease.
Eur Heart J 2010;
31: 2601-2613.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.